Skip to content
healthcare.dev

Tiopronin

NDC 44523-055, Tiopronin, tablet, delayed release, from BioComp Pharma, Inc..

Product NDC
44523-055
Status
Listed
Labeler
BioComp Pharma, Inc.
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA211843
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/44523-055 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIOPRONIN300 mg/1

Pharmacologic classes

Cystine Disulfide Reduction [MoA]; N-substituted Glycines [CS]; Reducing and Complexing Thiol [EPC]

Package NDCNDC-11Package
44523-055-014452300550190 TABLET, DELAYED RELEASE in 1 BOTTLE (44523-055-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1f2eb1d6-faa6-e352-e063-6294a90a7fb5

Use it

Look up 44523-055 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/44523-055 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 44523-055. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.